Jennifer M. Driscoll

Jennifer Driscoll focuses her practice on investigations, litigation, arbitration, mergers, and counseling. Jen has extensive experience in the medical devices, pharmaceutical, electronic components and automotive industries, with a particular knowledge of industries in Japan and Taiwan. She is a member of the firm’s Business Litigation Group.

An experienced commercial litigator, Jen defends corporations and individuals against alleged antitrust and anti-corruption claims, both civil and criminal. Her recent cases, which include cartel matters, safety audits and agency inquiries, reflect her skills with government investigations and compliance issues. Jen has represented clients in international cartel investigations, merger investigations, and Sherman Act Section Two class action lawsuits in federal courts. She has also counseled international clients about antitrust laws relating to mergers and acquisitions, represented both corporations and individuals in the Antitrust Division’s investigation of the auto parts industry, and defended clients in federal and multi-state investigations involving the False Claims Act and consumer product issues. Jen has been a member of panels discussing antitrust issues, international cartels and unilateral conduct, both in the U.S. and abroad, and has written articles and papers on these topics.

Among her recent matters, Jen represented a Taiwanese electronics manufacturer in merger analysis and Hart-Scott-Rodino filing and a Japanese medical device manufacturer in a False Claims Act investigation and litigation by the U.S. Department of Justice and U.S. Attorneys’ Office, serving as lead attorney and engaging in all aspects of the investigation, including government meetings and proffers, witness interviews, document productions and compliance with data privacy regulations and GDPR. She achieved a settlement without any penalties imposed on the client.

Jen is active in the American Bar Association’s Section of Antitrust Law, where she serves as Vice Chair of the Section’s Corporate Counseling Committee and Vice Chair to the Section’s U.S. Comments and Policy Committee during the 2022-2023 Section year.